More importantly, FAP-positive CAFs are often abundant in the tumor microenvironment in more than 90% of epithelial carcinomas, while the FAP expression in normal tissues is usually undetectable [1], thereby making FAP a promising pan-tumor target for cancer diagnosis and therapy [1, 2]. This evidence concerns the gene FAP and cancer.